The glycosylation of pterostilbene by cultured plant cells of Phytolacca americana gave pterostilbene 4'-O--D-glucoside. Both pterostilbene and its 4'-O-β-Dglucoside induced type XVII collagen expression in the EpiDermFT EFT-400 human skin cell model. Pterostilbene 4'-O-β-D-glucoside strongly induced type XVII collagen expression rather than pterostilbene.
Recently, it has been reported that the aging of hair follicle stem cells is triggered by DNA damage induced type XVII collagen (COL17A1) proteolysis [1] . Once aged hair follicle stem cells are activated during the hair cycle, they leave the niche and terminally differentiate into epidermal keratinocytes and are then eliminated from the skin surface.
Glycosylation occurs readily in plant cells, i.e., many kinds of secondary metabolites such as saponins and anthocyanins are produced in the form of glycosides in higher plants. Many of these secondary metabolites exert specific physiological activities and have been widely used in folk medicines [2] . Therefore, the glycosides of natural compounds are of pharmaceutical importance. Although studies on the production of glycosides of stilbenes have been reported [3] [4] [5] , there are few reports on their physiological activities.
Herein, we report, for the first time, the rapid induction of type XVII collagen (COL17A1) expression in hair follicle stem cells by a pterostilbene glucoside.
The level of type XVII collagen (COL17A1) was examined in the cells of the EpiDermFT EFT-400 human skin model treated with pterostilbene (1) and pterostilbene 4'-O--D-glucoside (2) ( Figure  1 ), which had been prepared by glycosylation of pterostilbene with cultured cells of P. americana. One week after treatment of the cells of the EpiDermFT EFT-400 human skin model with pterostilbene (1), the COL17A1 level was increased in the cells ( Figure 2 ). The level was enhanced dose dependently; the COL17A1 level of the 50 M pterostilbene-treated cells (1.35) was higher than that of the 25 M pterostilbene-treated cells (1.13). The level of the 50 M pterostilbene-treated cells was elevated in the cells by ca. 1.35-fold, compared with that of control cells, but the 100 M pterostilbenetreatment significantly reduced the COL17A1 level (0.69), probably due to the cytotoxicity of the pterostilbene. 
Experimental
General: Pterostilbene used as a substrate was purchased from Wako Pure Chemicals Co. and was used without further purification. The cultured plant cells of Phytolacca americana were sub-cultured at 4-week intervals on a solid medium containing 2% glucose, 1 ppm 2,4-dichlorophenoxyacetic acid, and 1% agar (adjusted to pH 5.7) in the dark. A suspension culture was started by transferring 20 g of the cultured cells into 300 mL of liquid Murashige and Skoog medium in a 500 mL-conical flask.
Biotransformation procedure: The suspension plant cells (20 g) were incubated in conical flasks for 2 days. The cultured cells in the stationary growth phase were used for the experiments. After the cultivation period, 10 mg of the substrate was added. The biotransformation was performed by incubating the mixture at 25°C on a rotary shaker for 2 days. The culture medium and cells were separated by filtration. The culture medium was extracted with ethyl acetate. The cells were extracted (x3) by homogenization with methanol. The methanol fraction was concentrated and partitioned between H 2 O and ethyl acetate. The ethyl acetate fractions were concentrated and analyzed by HPLC. The yield of product was determined on the basis of the peak area from HPLC using a calibration curve prepared with authentic glycosides.
Western blot analyses:
EpiDermFT EFT-400 human skin culture cells (MatTek Corp., Ashland, MA, USA) were cultivated at 37°C in a 10% CO 2 atmosphere for 24 h before being mixed with 25, 50, and 100 M of either pterostilbene or pterostilbene 4'-O--Dglucoside. After one week of incubation with the compounds, the cells were lysed, sonicated, and analyzed by Western blot analysis using anti-collagen XVII antibody (Abcam, Cambridge, MA, USA) and anti-GAPDH antibody (standard) (Sigma-Aldrich, St. Louis, MO, USA). The protein solution was fractionated by 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred onto nitrocellulose membranes. Membranes containing fractionated proteins were blotted with anti-collagen XVII antibody. Membranes were then blotted with horseradish peroxidase conjugated second antibody and the immunoreactive protein bands were visualized by enhanced chemiluminescence.
